Pricing Log in Create free account

Bone Biologics Corp. (BBLG) vs Valion Bio, Inc. (VBIO)

Bone Biologics Corp. and Valion Bio, Inc. are both Biotechnology companies. Bone Biologics Corp. and Valion Bio, Inc. are of similar size ($1.1M and $1.1M). Across the 10 metrics below, Bone Biologics Corp. leads on 8 and Valion Bio, Inc. on 2.

Valuation

Metric BBLG VBIO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.14 9.40
P/B 0.20 0.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 11.09 9.02
Earnings yield (438.22%) (40,026.00%) (32.88%)
Free cash flow yield (214.89%) (22,510.36%) (23.13%)

Profitability

Metric BBLG VBIO Biotechnology median
Gross margin — (58.09%) 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.49%) (489.30%) (51.96%)
Return on assets (44.46%) (104.96%) (46.06%)
Return on invested capital 0.00% (61.01%) 0.00%

Growth

Metric BBLG VBIO Biotechnology median
Revenue growth (TTM) — (49.63%) 6.76%
EPS growth (last fiscal year) 90.85% 60.16% 29.88%
Revenue growth, 5-year CAGR — 13.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG VBIO Biotechnology median
Debt to equity 0.00 0.62 0.00
Current ratio 13.38 1.11 4.97
Net debt to EBITDA 1.65 0.79 1.01

Dividend

Metric BBLG VBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BBLG VBIO Biotechnology median
Market cap 1.10m 1.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack